Literature DB >> 24163864

Dislocation of temporomandibular joint: complication of sagittal split ramus osteotomy.

Nobuyuki Mitsukawa, Tadashi Morishita, Atsuomi Saiga, Yoshitaka Kubota, Naoko Omori, Shinsuke Akita, Kaneshige Satoh.   

Abstract

Sagittal split ramus osteotomy (SSRO) has wide-ranging indications and results in simultaneous improvements in occlusion and facial appearance. Thus, it is the most frequently used osteotomy for jaw deformities. Its main intraoperative and postoperative complications are massive bleeding, atypical fractures, inferior alveolar nerve paralysis, and relapse. This report describes a case of temporomandibular joint dislocation, a rare complication of SSRO. The patient was a 23-year-old man with mandibular prognathism which was treated by bilateral SSRO. Postoperative x-ray showed that the left temporomandibular joint was dislocated anteriorly. Thus, the patient underwent reoperation, including reduction and re-fixation. Subsequently, it was discovered that the patient had a previous history of recurrent dislocation of the temporomandibular joint. This case illustrates the need for practitioners to be mindful of temporomandibular joint dislocation as a rare complication of SSRO.

Entities:  

Mesh:

Year:  2013        PMID: 24163864     DOI: 10.1097/scs.0b013e31828f2812

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

1.  Professional oral health care reduces the duration of hospital stay in patients undergoing orthognathic surgery.

Authors:  Hideo Shigeishi; Mohammad Zeshaan Rahman; Kouji Ohta; Shigehiro Ono; Masaru Sugiyama; Masaaki Takechi
Journal:  Biomed Rep       Date:  2015-11-10

2.  The influence of bilateral sagittal split ramus osteotomy on the stress distributions in the temporomandibular joints of the patients with facial asymmetry under symmetric occlusions.

Authors:  Jing-Heng Shu; Jie Yao; Yuan-Li Zhang; Desmond Y R Chong; Zhan Liu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.